Assessment of the growth fraction of non-
Abstract
Assessment of the growth fraction of nonHodgkin's lymphomas may provide useful additional prognostic information to that obtained with conventional histological criteria. The monoclonal antibody has been reported to provide such information immunocytochemically in tissue biopsy specimens from lymphoma as well as other tumours. This study was undertaken to assess whether this approach could be extended to fine needle aspiration (FNA) biopsy specimens which are becoming increasingly important in the diagnosis of lymphoma. In 21 cases of non-Hodgkin's lymphoma the rate of tumour proliferation estimated by immunostaining of FNA material, obtained from surgically removed specimens, was compared with that obtained on tissue biopsy. The correlation between both preparations was exellent, indicating that FNA biopsy material is suitable for the immunocytochemical assessment of the growth fraction of non-Hodgkin's lymphoma.
Histological criteria for subtyping nonHodgkin's lymphoma are an important factor in planning treatment regimens and for predicting clinical outcome.' S-uch classifications predict the overall clinical features of a group ofpatients with the same type of tumour, but the prognostic value for an individual patient is limited by wide variation in individual behaviour of lymphomas within each subgroup. This is particularly true for a number of tumours of low grade histological type but which follow a rapidly progressive clinical course. If such tumours could be identified earlier their outcome could be modified by using treatment better suited to a high grade tumour. This might be achieved by measuring the growth fraction of a tumour as this is believed to be an important factor determining response to treatment and survival.2
Previous studies of the proliferation in nonHodgkin's lymphoma using autoradiography,3 flow cytometry,4 tritiated thymidine incorporation5 and transferrin receptor detection6 have shown a good correlation between the rate of proliferation and other indicators of therapeutic outcome or survival. These techniques have not been widely introduced into pathological practice, either because they are too time consuming (autoradiography) or inaccurate (anti-transferrin receptor antibody).
Ki-67 is a monoclonal antibody which recognises a nuclear associated antigen expressed in all phases of the cell cycle except Go.7 Measurements of proliferation made with Ki-67 correlate well with other more conventional methods of assessing cell proliferation-for example, tritiated thymidine and bromodeoxyuridine incorporation.8 It has been shown to be of value in assessing the proliferative rate of many tumours such as those of the breast,9 lung,'0 cervix,"1 and lymphomal2'-4 by immunostaining cryostat sections of surgically excised biopsy specimens. For lymphoma, in particular, it has been shown that patients with histologically low grade non-Hodgkin's lymphoma and high proliferation rates have a worse clinical course than patients with low proliferation rates. 1 Fine needle aspiration biopsy is increasingly being used for the diagnosis of lymphoproliferative disorders'6 and has been shown to be suitable for immunocytochemical analysis.7-20 If immunocytochemical measurement of proliferation is confirmed as an important variable in the management of lymphoma then it will be necessary to perform such measurements on fine needle aspiration material. The aim of the present study was therefore to assess the suitability of fine needle aspiration biopsy specimens, obtained from fresh surgically resected specimens, for Ki-67 immunostaining and to compare results achieved with those on cryostat sections from the same tumours.
Methods
Eighteen lymph nodes and three spleens from patients with non-Hodgkin's lymphomas were resected surgically and received fresh in the laboratory. Material was aspirated from these using a 21 gauge fine needle and a 10 ml plastic syringe held in a lightweight aluminium holder (Cameco, Sweden). Smear preparations were stained by both Papanicolau and Giemsa methods. Whenever possible, a third air dried smear was prepared for immunostaining. The remaining material was suspended in 5 ml of tissue culture fluid (RPMI, Gibco) by drawing fluid into the syringe, and after disconnecting the needle (to minimise trauma to the cells), expelling it back into an appropriate tube. Twelve cytospins were prepared (Shandon cytospin 2; 550 rpm for five minutes) using about 250 ,ul of the cell suspension for each Immunocytochemical staining was performed using the alkaline phosphatase antialkaline phosphatase technique (APAAP), as described previously.2'
For the first 10 cases in this study, Ki-67 staining was assessed by counting the number of positively labelled cells in five randomly selected areas of 2 mm2 as described previously." This permitted the cases to be categorised into three grades as follows: grade cb/cc **********cytoplasmic staining********** 13 cb/cc **********cytoplasmic staining********** Two cases of follicular lymphoma (centroblastic/centrocytic) had to be eliminated from the study because of cytoplasmic staining in the cytospin preparations which made assessment of nuclear staining impossible. Cytospin and smear preparations gave the same proliferative grade in each of the six smear cases for which both type of preparation was available.
There was complete agreement in proliferation grade between cytological and histological preparations in 16 of the 19 cases studied. In the remaining three cases, all follicular lymphomas (centroblastic/centrocytic) in the fine needle aspiration biopsy specimen gave a lower proliferative grade than in the cryostat sections.
The correlation between histological grade (low and high) and Ki-67 proliferation grade was good. All high grade lymphomas had Ki In conclusion, using material aspirated from surgically resected specimens, the present study has shown that monoclonal antibody Ki67 is suitable for use with fine needle aspiration biopsy specimens in the assessment of growth fraction in non-Hodgkin's lymphoma. Although biopsy tissue is likely to remain the mainstay of lymphoma diagnosis, fine needle aspiration investigation is likely to increase as a simple investigation for excluding non-malignant conditions and for those patients in whom a biopsy is inappropriate. It will be important, then, to determine the importance of Ki-67 in lymphoma fine needle aspiration specimens to know whether the information is of value to clinical management. In addition, fine needle aspiration may become an auxiliary investigation for monitoring the course of a lymphoma during treatment. For example, it could be envisaged that serial Ki-67 measurements of low grade nonHodgkin's lymphomas might detect a progression to high grade type before it becomes clinically manifest, so that optimal treatment could be undertaken. 
